CHGCF OTC
Chugai Pharmaceutical Co., Ltd.
1W: -7.8%
1M: -8.0%
3M: -15.9%
YTD: -27.1%
1Y: -13.9%
3Y: +30.4%
5Y: +6.2%
$38.27
+0.43 (+1.13%)
Weekly Expected Move ±14.7%
$27
$33
$38
$44
$50
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$2.47T
+11.9% ▲
5Y CAGR: +14.9%
Total Liabilities
$443.2B
+44.4% ▲
5Y CAGR: +11.6%
Shareholders Equity
$2.03T
+6.6% ▲
5Y CAGR: +15.7%
Cash & Investments
$980.6B
-1.6% ▼
5Y CAGR: +21.0%
Total Debt
$25.7B
+136.1% ▲
5Y CAGR: +40.9%
Net Debt
-$401.2B
+24.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $267.8B | $222.2B | $458.7B | $540.2B | $427.0B |
| Short-Term Investments | $204.2B | $280.9B | $280.3B | $456.1B | $553.6B |
| Cash & ST Investments | $472.0B | $503.1B | $739.0B | $996.3B | $980.6B |
| Net Receivables | $355.1B | $512.5B | $318.9B | $334.3B | $443.5B |
| Inventory | $208.8B | $292.2B | $273.5B | $240.1B | $277.1B |
| Other Current Assets | $10.5B | $9.9B | $13.2B | $12.4B | $41.1B |
| Total Current Assets | $1.06T | $1.34T | $1.37T | $1.61T | $1.74T |
| Property, Plant & Equip. | $352.1B | $386.7B | $420.7B | $441.6B | $479.9B |
| Goodwill & Intangibles | $22.0B | $25.1B | $19.9B | $17.9B | $54.6B |
| Long-Term Investments | -$201.8B | -$279.1B | $1.3B | $73.1B | $8.5B |
| Other Non-Current Assets | $246.5B | $335.3B | $124.3B | $69.8B | $97.1B |
| Total Non-Current Assets | $475.0B | $533.2B | $566.1B | $602.3B | $728.5B |
| Total Assets | $1.54T | $1.87T | $1.93T | $2.21T | $2.47T |
| — Liabilities — | |||||
| Accounts Payable | $152.3B | $209.8B | $112.5B | $65.4B | $127.4B |
| Short-Term Debt | $0 | $0 | $0 | $0 | $7.8B |
| Deferred Revenue | $86M | $79M | $0 | $0 | $0 |
| Other Current Liabilities | $134.1B | $169.6B | $124.1B | $169.3B | $185.2B |
| Total Current Liabilities | $327.4B | $423.7B | $288.2B | $290.4B | $411.4B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $15.6B | $14.0B | $12.3B | $12.0B | $9.2B |
| Total Non-Current Liabilities | $23.3B | $21.6B | $18.8B | $16.5B | $31.8B |
| Total Liabilities | $350.7B | $445.4B | $307.0B | $306.9B | $443.2B |
| — Equity — | |||||
| Common Stock | $73.2B | $73.2B | $73.2B | $73.2B | $73.3B |
| Retained Earnings | $1.05T | $1.29T | $1.49T | $1.75T | $1.89T |
| Accumulated OCI | -$7.5B | -$11.0B | -$5.7B | $11.5B | -$8.0B |
| Total Stockholders Equity | $1.19T | $1.42T | $1.63T | $1.90T | $2.03T |
| Total Liabilities & Equity | $1.54T | $1.87T | $1.93T | $2.21T | $2.47T |
| — Key Metrics — | |||||
| Total Debt | $16.0B | $14.1B | $13.5B | $10.9B | $25.7B |
| Net Debt | -$251.7B | -$208.1B | -$445.2B | -$529.3B | -$401.2B |
| Total Investments | $2.4B | $1.8B | $280.3B | $529.2B | $562.0B |